Janesville, WI – According to filings with the U.S. Securities and Exchange Commission, Illuminated Holdings dba SHINE Medical Technologies is raising $131,728,550.00 in new funding. Sources indicate as part of senior management President and Chief Financial Officer, Todd Asmuth played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Illuminated Holdings dba SHINE Medical Technologies

SHINE Medical Technologies is dedicated to being the world leader in safe, clean, affordable production of medical tracers and cancer treatment elements. Founded in 2010 to manufacture and sell medical isotopes into an existing global market that serves over 40,000 patients per day in the United States, SHINE anticipates producing enough molybdenum-99 to meet two-thirds of US demand by 2018. With 30 employees and offices in Monona, SHINE has received financial support from angel and venture investors, the Morgridge Institute for Research and the US Department of Energy.

To learn more about Illuminated Holdings dba SHINE Medical Technologies, visit http://www.shinemed.com/

Contact:
Todd Asmuth, President and Chief Financial Officer
608-210-1060
todd.a@shinemed.com
https://www.linkedin.com/in/todd-asmuth-66050b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved